Healix Relocates to New State-of-the-Art Pharmacy Facility in Sugar Land, Texas


SUGAR LAND, TX (July 28, 2017) – Healix Infusion Therapy, Inc. is proud to announce the relocation of its pharmacy operation to a new, state-of-the-art facility in Sugar Land, Texas. With more than 28 years of sterile compounding services, the Healix Infusion Therapy pharmacy provides traditional patient-specific pharmacy compounding nationwide for the physician and hospital markets, including anti-infectives, chemotherapy and adjuvant medications, parenteral nutrition, and subcutaneous immunoglobulin.

“We are extremely excited about our new facility. With its advanced quality control measures and design, the facility will allow us to accommodate future growth as we continue to successfully provide patient-specific medications to our clients,” said Lucinda Van Anglen, B.S., Pharm.D., Senior Vice President of Pharmacy.

Healix Infusion Therapy, Inc. is an accredited pharmacy facility that meets or exceeds United States Pharmacopeia (USP) industry standards, with a focus on chapters USP <797> and USP <800>. The facility’s unique design complies with USP <800> for preparation, handling, and storage of hazardous drugs.

The Healix Infusion Therapy pharmacy is located at 1330 Industrial Blvd., Suite 100, Sugar Land, Texas 77478.


Since 1989, Healix has been driven by its mission of helping healthcare providers offer excellent patient care. With corporate headquarters in Sugar Land, Texas, Healix is a national leader in the provision of expert infusion therapy management solutions and high-quality sterile compounded preparations. Visit www.healix.net for more information.

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.